Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch
  

Opko Health Inc patents

Recent patent applications related to Opko Health Inc. Opko Health Inc is listed as an Agent/Assignee. Note: Opko Health Inc may have other listings under different names/spellings. We're not affiliated with Opko Health Inc, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "O" | Opko Health Inc-related inventors




Date Opko Health Inc patents (updated weekly) - BOOKMARK this page
10/05/17Nk1 antagonists
02/02/17Nk 1 antagonists
01/12/17Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
09/01/16Hypersulfated disaccharide formulations
05/26/16Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
01/28/16Intravenous formulations of neurokinin-1 antagonists
10/08/15Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
10/08/15Hypersulfated disaccharides to treat elastase related disorders
07/30/15Hydrochloride salts of 8-[1-(3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diazaspiro[4,5]decan-2-one and preparation process therefor
03/27/14Pharmaceutical formulations: salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
01/30/14Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
01/23/14Process and intermediates for the synthesis of 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one compounds
12/26/13Hypersulfated disaccharide formulations
08/08/13Hypersulfated disaccharides to treat elastase related disorders
05/16/13Tablet formulations containing 8-[-methyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one salts and tablets made therefrom
01/24/13Nk1 antagonists
11/22/12Nk1 antagonists
01/19/12Pharmaceutical formulations:salts of 8-[1-3,5-bis-(trifluoromethyl)phenyl)-ethoxymethyl]-8-phenyl-1,7-diaza-spiro[4.5]decan-2-one and treatment methods using the same
10/06/11Hypersulfated glucopyranosides
06/09/11Hypersulfated disaccharide formulations
04/28/11Nk1 antagonists
02/17/11Intravenous formulations of neurokinin-1 antagonists
07/29/10Nk 1 antagonists







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Opko Health Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Opko Health Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';